U
JAZZ icon

UBS’s Jazz Pharmaceuticals JAZZ Stock Holding History

UBS’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.06M Sell
6,600
-160,200
-96% -$24.6M ﹤0.01% 3529
2014
Q2 		$24.5M Buy
166,800
+164,500
+7,152% +$22.8M 0.02% 767
2014
Q1 		$319K Sell
2,300
-8,100
-78% -$1.22M ﹤0.01% 4697
2013
Q4 		$1.32M Sell
10,400
-11,600
-53% -$1.2M ﹤0.01% 3236
2013
Q3 		$2.02M Buy
22,000
+17,400
+378% +$1.4M ﹤0.01% 2569
2013
Q2 		$316K Buy
+4,600
New +$281K ﹤0.01% 4584

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's JAZZ Position: Q3 2014 in Review

UBS reduced its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q3 2014, selling an estimated $28.7M and leaving 145,410 shares worth $23.3M. The position accounts for 0.02% of the portfolio, ranked #867.

UBS first reported a position in JAZZ in Q2 2013 and has held it in 6 quarters since. The position peaked at $48.9M in Q2 2014. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

  • UBS held 145,410 shares of Jazz Pharmaceuticals worth $23.3M as of Q3 2014.
  • UBS sold 186,966 Jazz Pharmaceuticals shares in Q3 2014, an estimated $28.7M.
  • Jazz Pharmaceuticals made up 0.02% of UBS's portfolio in Q3 2014, its #867 holding.
  • UBS first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • UBS's Jazz Pharmaceuticals position peaked at $48.9M in Q2 2014.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.